These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30844223)

  • 1. Prescription Drug and Alcohol Use Disorders: Alcohol Use Disorder.
    Warren D
    FP Essent; 2019 Mar; 478():30-42. PubMed ID: 30844223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment of alcohol use disorder. Scientific evidence.
    Attilia F; Perciballi R; Rotondo C; Capriglione I; Iannuzzi S; Attilia ML; Vitali M; Alessandrini G; Scamporrino MCM; Fiore M; Ceccanti M;
    Riv Psichiatr; 2018; 53(3):123-127. PubMed ID: 29912214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medications for Alcohol Use Disorder.
    Poorman E; McQuade BM; Messmer S
    Am Fam Physician; 2024 Jan; 109(1):71-78. PubMed ID: 38227873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacotherapy of alcohol withdrawal: update and new developments].
    Soyka M; Rösner S
    Nervenarzt; 2021 Jan; 92(1):57-65. PubMed ID: 32696076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Alcohol Use Disorder.
    Patel AK; Balasanova AA
    JAMA; 2021 Feb; 325(6):596. PubMed ID: 33560323
    [No Abstract]   [Full Text] [Related]  

  • 6. Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
    Castrén S; Mäkelä N; Alho H
    Curr Opin Psychiatry; 2019 Jul; 32(4):266-274. PubMed ID: 30973369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
    Kranzler HR; Soyka M
    JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
    Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
    J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The state of pharmacotherapy for the treatment of alcohol dependence.
    Garbutt JC
    J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical management of alcohol use disorders].
    Paille F
    Rev Prat; 2019 Oct; 69(8):909-916. PubMed ID: 32237660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
    Williams EC; Matson TE; Harris AHS
    Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
    J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of Alcohol Use Disorder.
    Kranzler HR
    Am J Psychiatry; 2023 Aug; 180(8):565-572. PubMed ID: 37525595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of alcoholism - an update on approved and off-label medications.
    Soyka M; Müller CA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1187-1199. PubMed ID: 28658981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
    Petrakis IL; Nich C; Ralevski E
    Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing drugs for treatment of alcohol use disorder.
    Aubin HJ
    Int Rev Neurobiol; 2024; 175():153-185. PubMed ID: 38555115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Pharmacotherapy Development: Human Clinical Studies.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
    Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis.
    Avanceña ALV; Miller N; Uttal SE; Hutton DW; Mellinger JL
    J Hepatol; 2021 Jun; 74(6):1286-1294. PubMed ID: 33326815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.